Laxmi Dental Limited has submitted its monitoring agency report for the quarter ended September 30, 2025, detailing the utilization of proceeds from its Initial Public Offering (IPO) launched in January 2025. The report, prepared by ICRA Limited, confirms that there has been no material deviation from the stated objectives of the issue.

IPO Proceeds and Allocation

The company raised Rs. 138.00 crore through its IPO, with the funds allocated for various purposes:

Utilization Status

As of September 30, 2025, Laxmi Dental Limited has utilized Rs. 73.81 crore of the IPO proceeds, with Rs. 64.19 crore remaining unutilized. The company has completed its debt repayment objectives on schedule, while capital expenditure and subsidiary investments are partially completed and expected to be deployed within the current fiscal year.

Investment of Unutilized Funds

The unutilized funds are primarily invested in fixed deposits with ICICI Bank, earning returns ranging between 2.75% to 7.30%.

Monitoring Agency Confirmation

ICRA Limited, serving as the monitoring agency, has confirmed that there has been no material deviation from the objects of the issue as stated in the offer document.

This report demonstrates Laxmi Dental Limited's commitment to transparent financial practices and adherence to its stated objectives for the IPO proceeds. The company's progress in utilizing the funds for debt repayment and ongoing investments in capital expenditure and subsidiaries indicates a strategic approach to strengthening its financial position and expanding its operational capabilities.

Laxmi Dental Limited , a prominent player in the dental products industry, has reported robust financial results for the second quarter of fiscal year 2025-26, demonstrating significant growth across key metrics.

Financial Highlights

• Revenue: Grew by 26.5% year-over-year to ₹723.00 million, marking the company's strongest quarterly revenue. This represents a 10.2% increase quarter-over-quarter.
• EBITDA Margin: Maintained at 15.3%
• PAT Margin: Sustained at 10.5%

Segment Performance

The company's growth was driven by strong performances across its business segments:

Scanner Sales

Surged 94.7% year-over-year, with units sold in the first half of FY26 already exceeding the entire FY25 volume.

Dental Lab Business

Grew 29.9% year-over-year, driven by both domestic and international market traction.

Aligner Solutions

Recorded 12.3% year-over-year growth, primarily driven by Taglus which grew 29.9%.

Kids-E-Dental

Showed recovery with 21.4% quarter-over-quarter growth.

Strategic Focus

Laxmi Dental continues to invest in:

• Automation
• Research and Development
• Brand building
• Digital dentistry
• AI innovation

Future Outlook

Despite global uncertainties, Laxmi Dental has maintained strong margins and demonstrated robust growth across various segments. The company's focus on innovation, particularly in digital dentistry and AI, along with its strong performance in scanner sales and the dental lab business, positions it well for continued growth.

Investors and analysts will be keeping a close eye on Laxmi Dental's continued execution of its growth strategy in the coming quarters.

Note: All financial figures are in Indian Rupees (₹).